Do circulating antibodies against C1q reflect the activity of lupus nephritis?

Polskie Archiwum Medycyny Wewnetrznej

Volumn 121, Issue 9, 2011, Pages 287-294

  Smykał Jankowiak, Katarzyna ^a   Niemir, Zofia I ^a   Polcyn Adamczak, Magdalena ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Anti C1q and anti dsDNA antibodies; C3 and C4; Circulating immune complexes; Hematuria; Lupus nephritis

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; METHYLPREDNISOLONE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEMATURIA; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; PREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TURBIDIMETRY; URINARY CAST;

EID: 80053354004     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1077     Document Type: Article

References (36)

1. Nauta AJ, Trouw LA, Daha MR, et al. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol. 2002; 32: 1726-1736. (Pubitemid 34679160)
2. Bigler C, Schaller M, Perahud I, et al. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. J Immunol. 2009; 183: 3512-3521.
3. Mevorach D. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system. Apoptosis. 2010; 15: 1114-1123.
4. Stoyanova V, Petrova S, Tchorbadjieva M, et al. New insight into the autoimmunogenecity of complement protein C1q. Mol Immunol. 2011; 48: 678-682.
5. Morgan BP, Walport MJ. Complement deficiency and disease. Immunol Today. 1991; 12: 301-306.
6. Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res. 2002; 4: 279-293.
7. Smykał-Jankowiak K, Niemir ZI. [Structure and function of complement protein C1q and its role in the development of autoimmune diseases]. Postepy Hig Med Dosw. 2009; 63: 134-141. Polish.
8. Mannik M, Merrill CE, Stamps LD, Wener MH. Multiple autoantibodies from the glomerular immune deposits in patients with systemic lupuserythematosus. J Rheumatol. 2003; 30: 1495-1504. (Pubitemid 36835445)
9. Trouw LA, Seelen MA, Duijs JM, et al. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies. Clin Exp Immunol. 2003; 132: 32-39. (Pubitemid 36422600)
10. Trouw LA, Groeneveld TWL, Seelen MA, et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest. 2004; 114: 679-688. (Pubitemid 39578758)
11. Moroni G, Tredelenburg M, Del Papa N, et al. Anti-C1q antibodies may help diagnosing a renal flare in lupus nephritis. Am J Kidney Dis. 2001; 37: 490-498.
12. Marto N, Bertolaccini ML, Calabuig E, et al. Anti-C1q antibodies in nephritis: correlation between titres and rental disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis. 2005; 64: 444-448. (Pubitemid 40283057)
13. Rovin BH, Zhang X. Biomarkers for lupus nephritis: the quest continues. Clin J Am Soc Nephrol. 2009; 4: 1858-1865.
14. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002; 29: 288-291. (Pubitemid 34118775)
15. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revised. Kidney Int. 2004; 64: 521-530. (Pubitemid 38130646)
16. Meyer OC, Nicaise-Roland P, Cadoudal N, et al. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus. Arthritis Res Ther. 2009; 11: R87.
17. Flierman R, Daha MR. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis-a hypothesis. Mol Immunol. 2007; 44: 133-138. (Pubitemid 44754840)
18. Olesińska M, Chwalińska-Sadowska H, Wiȩsik-Szewczyk E, et al. Clinical manifestation of systemic lupus erythematosus in patients with antiribosomal P protein antibodies. Pol Arch Med Wewn. 2010; 120: 76-80.
19. Guerreiro de Moura CG, Pitangueira Mangueira CL, Sampaio Cruz LA, Sampaio Cruz CM. Negative anti-C1q antibody titres may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus. Nephron Clin Pract. 2011; 118: 355-360.
20. Moroni G, Radice A, Giammarresi G, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis. 2009; 68: 234-237.
21. Trendelenburg M, Lopez-Trascasa M, Potlukova E, et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant. 2006; 21: 3115-3121. (Pubitemid 44567082)
22. Cai X, Yang X, Lian F, et al. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis. J Rheumatol. 2010; 37: 759-765.
23. Isenberg DA, Manson JJ, Ehrenstein, et al. Fifty years of anti-dsDNA antibodies: are we approaching journey's end? Rheumatology (Oxford). 2007; 46: 1052-1056. (Pubitemid 47050602)
24. Mok CC, Ho LY, Leung HW, Wong LG. Performance of anti-C1q, antinucleosome, and and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Transl Res. 2010; 156: 320-325.
25. Isenberg DA, Ravirajan CT, Rahman A, Kalsi J. The role of antibodies to DNA in systemic lupus erythematosus - a review and introduction to an international workshop on DNA antibodies held in London, May 1996. Lupus. 1997: 6: 290-304. (Pubitemid 27160652)
26. Coremans IE, Spronk PE, Bootsma H, et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis. 1995; 26: 595-601.
27. Witte T, Hartung K, Sachse C, et al. IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group. Rheumatol Int. 1998; 18: 85-91. (Pubitemid 28505328)
28. Siegert C, Daha M, Westedt ML, et al. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol. 1991; 18: 230-234.
29. Renaudineau Y, Crouquefer S, Jousse S, et al. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum. 2006; 54: 2523-2532. (Pubitemid 44205013)
30. Siegert CE, Daha MR, Swaak AJ, et al. The relationship between serum titers of autoantibodies to C1q and age in general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1993; 67: 204-209. (Pubitemid 23186401)
31. Fremenaux-Bacchi V, Noël LH, Schifferli JA. No lupus nephritis in the absence of anti-C1q autoantibodies? Nephrol Dial Transplant. 2002; 17: 2041-2043.
32. Trendelenburg M, Marfurt J, Gerber I, et al. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum. 1999; 42: 187-188. (Pubitemid 29042588)
33. Fang QY, Yu F, Tan Y, et al. Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis. Nephrol Dial Transplant. 2009; 24: 172-178.
34. Bigler C, Hopfer H, Danner D, et al. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis. Nephrol Dial Transplant. 2011; 26: 1220-1228.
35. Sinico RA, Rimoldi L, Radice A, et al. Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci. 2009; 1173: 47-51.
36. Gunnarsson I, Sundelin B, Heimbürger M, et al. Repeated renal biopsy in proliferative lupus nephritis-predictive role of serum C1q and albuminuria. J Rheumatol. 2002; 29: 693-699. (Pubitemid 34303862)